Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Sciences,
Section of Pharmacology,
and National Institute of Neurosciences,
Department of Medical Sciences, Section of Pharmacology, and National Institute of Neurosciences
Mario Barbieri has not added Biography.
If you are Mario Barbieri and would like to personalize this page please email our Author Liaison for assistance.
Protective effect of darodipine, a calcium antagonist, on rat cardiomyocytes against oxygen radical-mediated injury.
British journal of pharmacology Dec, 1997 | Pubmed ID: 9421282
Mechanisms of action of CHF3381 in the forebrain.
British journal of pharmacology Aug, 2003 | Pubmed ID: 12890713
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the fibroblast growth factor-2 system.
Epilepsia , 2005 | Pubmed ID: 15987254
Fgf-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss.
The Journal of neuroscience : the official journal of the Society for Neuroscience Dec, 2008 | Pubmed ID: 19052202
Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
Neurochemistry international May-Jun, 2009 | Pubmed ID: 19418633
Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
Neuropharmacology Feb, 2010 | Pubmed ID: 19747494
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins.
Cell transplantation , 2012 | Pubmed ID: 22525962
Cellular resilience: 5-HT neurons in Tph2(-/-) mice retain normal firing behavior despite the lack of brain 5-HT.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Nov, 2015 | Pubmed ID: 26409296
Novel Synthetic Opioids: The Pathologist's Point of View.
Brain sciences Sep, 2018 | Pubmed ID: 30200549
University of ferrara
University of Ferrara and National Institute of Neuroscience
Universita degli Studi di Ferrara
Giovanna Paolone*,1,
Chiara Falcicchia*,1,
Gianluca Verlengia*,1,
Mario Barbieri1,
Anna Binaschi1,
Federico Paliotto1,
Beatrice Paradiso1,
Marie Soukupova1,
Silvia Zucchini1,2,
Michele Simonato1,2
1Department of Medical Sciences, Section of Pharmacology, and National Institute of Neurosciences, University of Ferrara,
2Laboratory for the Technologies for Advanced Therapies (LTTA), University of Ferrara
Marie Soukupová1,
Chiara Falcicchia1,
Francesca Lovisari1,
Selene Ingusci1,
Silvia Zucchini1,
Michele Simonato1
1Department of Medical Sciences, Section of Pharmacology, Neuroscience Center, University of Ferrara and National Institute of Neuroscience
Annunziata Guarino1,
Laila Asth1,
Pietro Marino1,
Michele Simonato1,
Silvia Zucchini1
1Department of Neuroscience and Rehabilitation, Section of Pharmacology, Universita degli Studi di Ferrara
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.